Concepedia

Vicki L. Coffin

VL

34

Publications

1.6K

Citations

21

H-Index

1983

Active since

Affiliations

Bloomfield College(Current)

Wayne State University

New England Biolabs (United States)

AGCO (United Kingdom)

Baton Rouge Clinic

Vicki L. Coffin is an author at Bloomfield College specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Top concepts

Publications per year

1983–2008

34

Publications

34

Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat

S. Barak Caine, Stephen C. Heinrichs, Vicki L. Coffin et al. · Brain Research · 1995 · 292 citations

, , +9

Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.

Richard E. Chipkin, Louis C. Iorio, Vicki L. Coffin et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 183 citations · Full text

Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine

Robin A. Barraco, Vicki L. Coffin, Harvey J. Altman et al. · Brain Research · 1983 · 128 citations

, , +8

Attenuation of the Euphoric Effects of Cocaine by the Dopamine D1/D5 Antagonist Ecopipam (SCH 39166)

Myroslava K. Romach, Paul Glue, Kyle M. Kampman et al. · Archives of General Psychiatry · 1999 · 117 citations

Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.

Vicki L. Coffin, Miklos B. Latranyi, Richard E. Chipkin · Journal of Pharmacology and Experimental Therapeutics · 1989 · 87 citations

Rows per page

1–5 of 34